
About Xylem Clinical Research Private Limited
Data last updated:
Xylem Clinical Research Private Limited was a private limited company based in Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the research and development sector. It was incorporated on 05 December 2008.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U73100DL2008PTC185551. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Sanjay Gupta and Shriram Arvind Inamdar.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at D – 21 Tandon Road Adarsh Nagar, Delhi, India – 110033.
The last known website on record is catalystclinicalservices.com.
Company details
Contact details
Xylem Clinical Research Private Limited's registered office is in Delhi, Delhi. Its website is catalystclinicalservices.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressD – 21 Tandon Road Adarsh Nagar, Delhi, India – 110033
- IndustryResearch & Development, Research & Development
To see the full contact details of Xylem Clinical Research Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Xylem Clinical Research Private Limited
FY 2023 filings availableXylem Clinical Research Private Limited reported revenue of ₹1,590 for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 72% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Xylem Clinical Research Private Limited, buy the company report.
Board of directors of Xylem Clinical Research Private Limited
Xylem Clinical Research has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Gupta | Director | 06 Jan 2012 | 14 Years 10 Months | As last reported |
| Shriram Arvind Inamdar Also directs: Xylem Research LLP | Director | 06 Jan 2012 | 14 Years 10 Months | As last reported |
Shareholding
The shareholding of Xylem Clinical Research Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Xylem Clinical Research Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Xylem Clinical Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Xylem Clinical Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Xylem Clinical Research has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Xylem Clinical Research Private Limited, buy the company report.
Recent activity
Xylem Clinical Research Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Aruna Gupta ceased to be Director on 30 Jan 2012.
Frequently asked questions
Xylem Clinical Research has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Xylem Clinical Research was a private limited company based in Delhi, India. The company worked in the research and development industry. It was incorporated on 05 December 2008 and is registered under CIN U73100DL2008PTC185551. The company has been struck off by the Registrar of Companies and is no longer operational.
Xylem Clinical Research had 2 directors:
- Sanjay Gupta - Director
- Shriram Arvind Inamdar - Director
The CIN (Corporate Identification Number) of Xylem Clinical Research is U73100DL2008PTC185551. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Xylem Clinical Research is at D – 21 Tandon Road Adarsh Nagar, Delhi, India – 110033.
Xylem Clinical Research was incorporated on 05 December 2008. It is registered with the Registrar of Companies, Delhi.
Xylem Clinical Research can be reached through the website catalystclinicalservices.com. Its registered office is in Delhi, India.
The latest financial statements of Xylem Clinical Research on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
No. Xylem Clinical Research has 1 GST registration on record and it is cancelled or inactive.
Xylem Clinical Research operated in the research and development industry. It worked in this industry before it was struck off.

